Medicare Reform Would Boost Entire U.S. Economy, Sen. Kerry Suggests
This article was originally published in The Gray Sheet
Executive Summary
Sen. John Kerry (D-Mass.) says he will work during the 107th Congress to eliminate the lengthy delays in securing reimbursement for new medical technology
You may also be interested in...
Medicare Delays Extend Time To Profitability For Device Firms - Lewin Group
Small device manufacturers that encounter a two-year delay in obtaining appropriate Medicare reimbursement must raise double the amount of capital in order to become profitable, according to a report released Aug. 7 by the Lewin Group.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.